Literature DB >> 33108522

Newly diagnosed isolated myeloid sarcoma-paired NGS panel analysis of extramedullary tumor and bone marrow.

Nils W Engel1, Jochim Reinert2, Nora M Borchert3, Victoria Panagiota3, Razif Gabdoulline3, Felicitas Thol3, Michael Heuser3, Walter Fiedler4.   

Abstract

Isolated myeloid sarcoma (MS) is a rare malignancy in which myeloid blast forms tumors at various locations while the bone marrow (BM) remains cytomorphologically free from disease. We analyzed isolated MS from four patients and their BMs at initial diagnosis and follow-up, using a custom next-generation sequencing (NGS) panel. We observed possible clonal evolution and a clonal hematopoiesis of indeterminate potential (CHIP)-like finding in the BM of one of three cases with detectable mutations. Clinical presentation of one patient suggested extramedullary confined homing of blasts to distal sites in the relapse situation still sparing the BM. In summary, our findings shall motivate future work regarding signals of extramedullary blast trafficking and clonal evolution in MS.

Entities:  

Keywords:  CHIP; Clonal evolution; Homing; Myeloid sarcoma; NGS sequencing

Mesh:

Year:  2020        PMID: 33108522      PMCID: PMC7817572          DOI: 10.1007/s00277-020-04313-x

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  17 in total

1.  Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.

Authors:  Michael Heuser; Razif Gabdoulline; Patrick Löffeld; Vera Dobbernack; Henriette Kreimeyer; Mira Pankratz; Madita Flintrop; Alessandro Liebich; Sabrina Klesse; Victoria Panagiota; Michael Stadler; Martin Wichmann; Rabia Shahswar; Uwe Platzbecker; Christian Thiede; Thomas Schroeder; Guido Kobbe; Robert Geffers; Brigitte Schlegelberger; Gudrun Göhring; Hans-Heinrich Kreipe; Ulrich Germing; Arnold Ganser; Nicolaus Kröger; Christian Koenecke; Felicitas Thol
Journal:  Ann Hematol       Date:  2017-06-13       Impact factor: 3.673

2.  Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.

Authors:  Felicitas Thol; Razif Gabdoulline; Alessandro Liebich; Piroska Klement; Johannes Schiller; Christian Kandziora; Lothar Hambach; Michael Stadler; Christian Koenecke; Madita Flintrop; Mira Pankratz; Martin Wichmann; Blerina Neziri; Konstantin Büttner; Bennet Heida; Sabrina Klesse; Anuhar Chaturvedi; Arnold Kloos; Gudrun Göhring; Brigitte Schlegelberger; Verena I Gaidzik; Lars Bullinger; Walter Fiedler; Albert Heim; Iyas Hamwi; Matthias Eder; Jürgen Krauter; Richard F Schlenk; Peter Paschka; Konstanze Döhner; Hartmut Döhner; Arnold Ganser; Michael Heuser
Journal:  Blood       Date:  2018-09-06       Impact factor: 22.113

Review 3.  Myeloid Sarcoma.

Authors:  Mohamed Magdy; Nagla Abdel Karim; Ihab Eldessouki; Ola Gaber; Mohamed Rahouma; Mohamed Ghareeb
Journal:  Oncol Res Treat       Date:  2019-03-06       Impact factor: 2.825

4.  Copy number alterations detected as clonal hematopoiesis of indeterminate potential.

Authors:  Koichi Takahashi; Feng Wang; Hagop Kantarjian; Xingzhi Song; Keyur Patel; Sattva Neelapu; Curtis Gumbs; Latasha Little; Samantha Tippen; Rebecca Thornton; Courtney D DiNardo; Farhad Ravandi; Carlos Bueso-Ramos; Jianhua Zhang; Xifeng Wu; Guillermo Garcia-Manero; P Andrew Futreal
Journal:  Blood Adv       Date:  2017-06-19

5.  Chemokine/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: differential roles for CCR2, CCR5, CXCR4 and CXCR7.

Authors:  Claudia M J M Faaij; Annemieke J Willemze; Tom Révész; Melania Balzarolo; Cornelis P Tensen; Manja Hoogeboom; Maarten H Vermeer; Elisabeth van Wering; Christian M Zwaan; Gertjan J L Kaspers; Colin Story; Astrid G S van Halteren; Jaak M Vossen; R Maarten Egeler; Maarten J D van Tol; Nicola E Annels
Journal:  Pediatr Blood Cancer       Date:  2010-08       Impact factor: 3.167

Review 6.  Clinical consequences of clonal hematopoiesis of indeterminate potential.

Authors:  David P Steensma
Journal:  Blood Adv       Date:  2018-11-27

7.  Granulocytic sarcoma in nonleukemic patients.

Authors:  J M Meis; J J Butler; B M Osborne; J T Manning
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

8.  Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases.

Authors:  R S Neiman; M Barcos; C Berard; H Bonner; R Mann; R E Rydell; J M Bennett
Journal:  Cancer       Date:  1981-09-15       Impact factor: 6.860

9.  Diagnosis of fusion genes using targeted RNA sequencing.

Authors:  Erin E Heyer; Ira W Deveson; Danson Wooi; Christina I Selinger; Ruth J Lyons; Vanessa M Hayes; Sandra A O'Toole; Mandy L Ballinger; Devinder Gill; David M Thomas; Tim R Mercer; James Blackburn
Journal:  Nat Commun       Date:  2019-03-27       Impact factor: 14.919

10.  Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing.

Authors:  Karl Kashofer; Max Gornicec; Karin Lind; Veronica Caraffini; Silvia Schauer; Christine Beham-Schmid; Albert Wölfler; Gerald Hoefler; Heinz Sill; Armin Zebisch
Journal:  Leuk Lymphoma       Date:  2017-06-20
View more
  2 in total

Review 1.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Authors:  Joseph D Khoury; Eric Solary; Oussama Abla; Yassmine Akkari; Rita Alaggio; Jane F Apperley; Rafael Bejar; Emilio Berti; Lambert Busque; John K C Chan; Weina Chen; Xueyan Chen; Wee-Joo Chng; John K Choi; Isabel Colmenero; Sarah E Coupland; Nicholas C P Cross; Daphne De Jong; M Tarek Elghetany; Emiko Takahashi; Jean-Francois Emile; Judith Ferry; Linda Fogelstrand; Michaela Fontenay; Ulrich Germing; Sumeet Gujral; Torsten Haferlach; Claire Harrison; Jennelle C Hodge; Shimin Hu; Joop H Jansen; Rashmi Kanagal-Shamanna; Hagop M Kantarjian; Christian P Kratz; Xiao-Qiu Li; Megan S Lim; Keith Loeb; Sanam Loghavi; Andrea Marcogliese; Soheil Meshinchi; Phillip Michaels; Kikkeri N Naresh; Yasodha Natkunam; Reza Nejati; German Ott; Eric Padron; Keyur P Patel; Nikhil Patkar; Jennifer Picarsic; Uwe Platzbecker; Irene Roberts; Anna Schuh; William Sewell; Reiner Siebert; Prashant Tembhare; Jeffrey Tyner; Srdan Verstovsek; Wei Wang; Brent Wood; Wenbin Xiao; Cecilia Yeung; Andreas Hochhaus
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

2.  Incidence, clinical characteristics, and prognostic nomograms for patients with myeloid sarcoma: A SEER-based study.

Authors:  Ziping Xing; Xiaohua Zhu; Zifeng Li; Hongsheng Wang; Maoxiang Qian; Xiaowen Zhai
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.